RESEARCH USE ONLY. UK DISPATCH. ≥98% PURITY. SAME DAY DISPATCH BEFORE 2 PM MON–FRI. NOT FOR HUMAN CONSUMPTION
Lynx Peptides
Basket 0

Preclinical evidence

Ipamorelin research overview

Review the published research context, areas studied and evidence limitations associated with this catalogue material.

Evidence context statedSources linkedLast reviewed

Research context

In vitro and animal studies have examined ipamorelin as a growth-hormone secretagogue, including receptor pharmacology, pituitary-cell responses and skeletal research in rats.

Areas studied

  • Growth-hormone secretagogue pharmacology
  • Pituitary somatotroph responses
  • Growth-hormone release in animal models
  • Skeletal research in rats

Limitations and investigational status

The cited evidence is preclinical and includes cell, rat and swine models. It does not establish therapeutic effects or suitability for human use.

References

  1. 1Raun et al. — European Journal of Endocrinology, 1998
  2. 2Jiménez-Reina et al. — Histology and Histopathology, 2002
  3. 3Svensson et al. — Journal of Endocrinology, 2000

For laboratory research use only. Information presented here summarises areas investigated in published research and is not intended as medical advice or as evidence of established effects in humans.